AtriCure Market Cap 2006-2019 | ATRC
AtriCure market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. AtriCure market cap as of July 17, 2019 is $1.2B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.196B | $0.202B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $151.296B | 28.49 |
| Medtronic (MDT) | Ireland | $135.350B | 19.33 |
| Stryker (SYK) | United States | $77.587B | 27.69 |
| Boston Scientific (BSX) | United States | $58.741B | 28.16 |
| Baxter (BAX) | United States | $42.165B | 26.58 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.527B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.661B | 40.97 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.304B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.194B | 16.19 |
| Terumo (TRUMY) | Japan | $22.193B | 25.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.113B | 0.00 |
| ResMed (RMD) | United States | $17.749B | 33.91 |
| Canopy Growth (CGC) | Canada | $12.652B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.175B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.194B | 48.74 |
| Aurora Cannabis (ACB) | Canada | $7.514B | 74.10 |
| William Demant Holdings (WILYY) | Denmark | $7.411B | 0.00 |
| Insulet (PODD) | United States | $7.236B | 527.17 |
| Hill-Rom Holdings (HRC) | United States | $7.121B | 21.59 |
| Perrigo (PRGO) | Ireland | $6.850B | 11.58 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.254B | 51.05 |
| ICU Medical (ICUI) | United States | $5.122B | 30.57 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.916B | 0.00 |
| Neogen (NEOG) | United States | $3.373B | 54.85 |
| NuVasive (NUVA) | United States | $2.987B | 24.39 |
| Hutchison China MediTech (HCM) | China | $2.906B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.848B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.479B | 52.82 |
| Quidel (QDEL) | United States | $2.261B | 23.46 |
| Aphria (APHA) | $1.646B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.530B | 878.80 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 18.16 |
| VAREX IMAGING (VREX) | United States | $1.177B | 24.98 |
| NanoString Technologies (NSTG) | United States | $1.065B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $1.052B | 27.95 |
| PetIQ (PETQ) | United States | $1.008B | 24.49 |
| Quanterix (QTRX) | United States | $0.783B | 0.00 |
| Cerus (CERS) | United States | $0.769B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.758B | 21.26 |
| Omeros (OMER) | United States | $0.758B | 0.00 |
| MacroGenics (MGNX) | United States | $0.740B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.686B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.591B | 28.62 |
| Surmodics (SRDX) | United States | $0.533B | 77.45 |
| OraSure Technologies (OSUR) | United States | $0.522B | 24.06 |
| Meridian Bioscience (VIVO) | United States | $0.489B | 14.96 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.398B | 0.00 |
| Vapotherm (VAPO) | United States | $0.337B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.325B | 22.51 |
| BioLife Solutions (BLFS) | United States | $0.313B | 97.88 |
| Zynex (ZYXI) | United States | $0.242B | 24.90 |
| Cytosorbents (CTSO) | United States | $0.234B | 0.00 |
| Bovie Medical (APYX) | United States | $0.224B | 0.00 |
| Chimerix (CMRX) | United States | $0.184B | 0.00 |
| Owens & Minor (OMI) | United States | $0.178B | 3.77 |
| United Health Products (UEEC) | United States | $0.175B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.168B | 0.00 |
| Female Health (VERU) | United States | $0.143B | 0.00 |
| Fonar (FONR) | United States | $0.141B | 7.40 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 19.97 |
| InfuSystems Holdings (INFU) | United States | $0.088B | 0.00 |
| Surface Oncology (SURF) | United States | $0.076B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.057B | 19.58 |
| MRI INTERVENTNS (MRIC) | United States | $0.053B | 0.00 |
